Augustin M, Bock PR, Hanisch J, et al. Safety and efficacy of the long-term adjuvant treatment of primary intermediate- to high-risk malignant melanoma (UICC/AJCC stage II and III) with a standardized fermented European mistletoe (Viscum album L.) extract. Results from a multicenter, comparative, epidemiological cohort study in Germany and Switzerland. Arzneimittelforschung 2005; 55 (1): 38-49.
Bradley GW, Clover A: Apparent response of small cell lung cancer to an extract of mistletoe and homoeopathic treatment. Thorax 1989; 44 (12): 1047-8.
Grossarth-Maticek R, Kiene H, Baumgartner SM, et al. Use of Iscador, an extract of European mistletoe (Viscum album), in cancer treatment: prospective nonrandomized and randomized matched-pair studies nested within a cohort study. Altern Ther Health Med 2001; 7 (3): 57-66, 68-72, 74-6 passim.
Heiny BM, Albrecht V, Beuth J. Stabilization of quality of life with mistletoe lectin-1-standardized extract in advanced colorectal carcinoma. Onkologe 1998; 4 (Suppl 1): S35-9.
Kienle GS, Berrino F, Büssing A, et al. Mistletoe in cancer - a systematic review on controlled clinical trials. Eur J Med Res 2003; 8 (3): 109-19.
Kleijnen J, Knipschild P. Mistletoe treatment for cancer: review of controlled trials in humans. Phytomedicine 1994; 1: 255-60.
Lenartz D, Stoffel B, Menzel J, et al. Immunoprotective activity of the galactoside-specific lectin from mistletoe after tumor destructive therapy in glioma patients. Anticancer Res 1996; 16 (6B): 3799-802.
Lenartz D, Dott U, Menzel J, et al.: Survival of glioma patients after complementary treatment with galactoside-specific lectin from mistletoe. Anticancer Res 2000: 20 (3B): 2073-6.
Leroi R. Postoperative Viscum album therapy after surgery of breast neoplasms. Helv Chir Acta 44 1977; (3): 403-14.
Salzer G, Havelec L. Adjuvant Iscador treatment after operated stomach cancer. Results of a randomized study. Dtsch Z Onkol 1983; 15 (4): 106-10.
Salzer G: Pleura carcinosis. Cytomorphological findings with the mistletoe preparation iscador and other pharmaceuticals. Oncology 1986; 43 (Suppl 1): 66-70.
Salzer G. Prospective randomized study: operated stomach cancer. Adjuvant treatment with Iscador--an unconventional consideration. Dtsch Z Onkol 1988; 20 (4): 90-3.
Salzer G, Danmayr E, Wutzholfer F, et al. Adjuvant Iscador® treatment of non-small cell bronchial carcinoma. Results of a randomized study. Dtsch Z Onkol 1991; 23 (4): 93-8.
Sauer H: Quality of life stabilization with mistletoe-1-standardized extract in advanced colorectal carcinoma (Letter). Onkologe 1998; 4: 1180.
Stauder H, Kreuser ED. Mistletoe extracts standardised in terms of mistletoe lectins (ML I) in oncology: current state of clinical research. Onkologie 2002; 25 (4): 374-80.
